{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:25:55Z","timestamp":1759400755921},"reference-count":29,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2001,12,25]],"date-time":"2001-12-25T00:00:00Z","timestamp":1009238400000},"content-version":"vor","delay-in-days":693,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Immunology"],"published-print":{"date-parts":[[2000,2]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>In this study, we investigated the potential of a DNA vaccine expressing the minimal cytotoxic T lymphocyte (CTL) epitope gp33 of the lymphocytic choriomeningitis virus glycoprotein to protect against infection of a non\u2010lymphoid organ and compared this to protection against a systemic infection. Furthermore, since immune stimulatory sequences have been shown to augment CTL responses, we examined the capacity of CpG DNA to enhance CTL memory. The data show that DNA vaccination with a gp33\u2010based gene construct induced short\u2010lived gp33\u2010specific CTL which protected against a systemic infection but not against a peripheral infection. Immune stimulatory sequences were incapable of either prolonging CTL memory or promoting protection against infection of a peripheral organ.<\/jats:p>","DOI":"10.1046\/j.1365-2567.2000.00950.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T02:26:44Z","timestamp":1047436004000},"page":"163-169","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Antiviral protection after DNA vaccination is short lived and not enhanced by CpG DNA"],"prefix":"10.1111","volume":"99","author":[{"given":"S.","family":"Oehen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Junt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"L\u00f3pez\u2010mac\u00edas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T. A. N.","family":"Kramps","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2001,12,25]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-5699(97)01201-2"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.15.1.617"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.273.5273.352"},{"key":"e_1_2_5_5_2","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.4049\/jimmunol.158.8.3635","article-title":"Contribution of CpG motifs to the immunogenicity of DNA vaccines","volume":"158","author":"Klinman D.M.","year":"1997","journal-title":"J Immunol"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/374546a0"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.187.7.1145"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm0897-849"},{"key":"e_1_2_5_9_2","doi-asserted-by":"crossref","first-page":"870","DOI":"10.4049\/jimmunol.160.2.870","article-title":"CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen","volume":"160","author":"Davis H.L.","year":"1998","journal-title":"J Immunol"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.20.10833"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.18.9716"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.14.1.333"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.2.640"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/0166-0934(91)90018-U"},{"key":"e_1_2_5_15_2","doi-asserted-by":"crossref","first-page":"4301","DOI":"10.4049\/jimmunol.146.12.4301","article-title":"Antiviral protection by CD8+ versus CD4+ T cells. CD8+ T cells correlating with cytotoxic activity in vitro are more efficient in antivaccinia virus protection than CD4\u2010dependent IL","volume":"146","author":"Binder D.","year":"1991","journal-title":"J Immunol"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1038\/386336a0"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830190302"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830270931"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1089\/oli.1.1998.8.351"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.161.10.5338"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.183.4.1367"},{"key":"e_1_2_5_22_2","doi-asserted-by":"crossref","first-page":"4010","DOI":"10.4049\/jimmunol.154.8.4010","article-title":"Protective CTL\u2010dependent immunity and enhanced immunopathology in mice immunized by particle bombardment with DNA encoding an internal virion protein","volume":"154","author":"Zarozinski C.C.","year":"1995","journal-title":"J Immunol"},{"key":"e_1_2_5_23_2","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.1128\/jvi.69.4.2574-2582.1995","article-title":"DNA vaccination against persistent viral infection","volume":"69","author":"Martins L.P.","year":"1995","journal-title":"J Virol"},{"key":"e_1_2_5_24_2","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1128\/jvi.69.4.2684-2688.1995","article-title":"DNA immunization confers protection against lethal lymphocytic choriomeningitis virus infection","volume":"69","author":"Yokoyama M.","year":"1995","journal-title":"J Virol"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.73.1.501-509.1999"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.72.2.1704-1708.1998"},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(95)80001-8"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.72.6.5174-5181.1998"},{"key":"e_1_2_5_29_2","doi-asserted-by":"publisher","DOI":"10.1038\/369652a0"},{"key":"e_1_2_5_30_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.1996.tb00696.x"}],"container-title":["Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2567.2000.00950.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2567.2000.00950.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2567.2000.00950.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T15:27:23Z","timestamp":1698593243000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2567.2000.00950.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,2]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2000,2]]}},"alternative-id":["10.1046\/j.1365-2567.2000.00950.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2567.2000.00950.x","archive":["Portico"],"relation":{},"ISSN":["0019-2805","1365-2567"],"issn-type":[{"value":"0019-2805","type":"print"},{"value":"1365-2567","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,2]]},"assertion":[{"value":"2001-12-25","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}